Quest Diagnostics Inc
DGX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|BD | LOCK|pC^ZZ | LOCK|$ds?w!G |
Quest Diagnostics Earnings: Robust Quarterly Results Held Few Surprises; Our Valuation Is Intact
Quest delivered third-quarter results that featured organic revenue growth of 4%, while acquisitions drove total revenue up by 13%. Profitability kept pace with adjusted EPS, growing 13% year over year.
